{"id":"https://openalex.org/W2903482389","doi":"https://doi.org/10.1158/1535-7163.mct-17-0857","title":"3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers","display_name":"3D Growth of Cancer Cells Elicits Sensitivity to Kinase Inhibitors but Not Lipid Metabolism Modifiers","publication_year":2018,"publication_date":"2018-11-26","ids":{"openalex":"https://openalex.org/W2903482389","doi":"https://doi.org/10.1158/1535-7163.mct-17-0857","mag":"2903482389","pmid":"https://pubmed.ncbi.nlm.nih.gov/30478149","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6611711"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-17-0857","doi":"https://doi.org/10.1158/1535-7163.mct-17-0857","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0857","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6611711","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011978635","display_name":"Dylan T. Jones","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Dylan T. Jones","raw_affiliation_strings":["1Target Discovery Institute, NDM Research Building, Old Road Campus, Headington, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Target Discovery Institute, NDM Research Building, Old Road Campus, Headington, Oxford, United Kingdom","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018317846","display_name":"Alessandro Valli","orcid":"https://orcid.org/0009-0001-3199-7785","observed_orcids":["https://orcid.org/0009-0001-3199-7785"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Alessandro Valli","raw_affiliation_strings":["2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052903538","display_name":"Syed Aleem Haider","orcid":"https://orcid.org/0000-0001-6685-5480","observed_orcids":["https://orcid.org/0000-0001-6685-5480"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]},{"id":"https://openalex.org/I2799938689","display_name":"Breast Cancer Now","ror":"https://ror.org/02qa92s63","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2799938689"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Syed Haider","raw_affiliation_strings":["2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","3Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"3Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616","https://openalex.org/I2799938689"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100661023","display_name":"Qifeng Zhang","orcid":"https://orcid.org/0000-0002-4795-2004","observed_orcids":["https://orcid.org/0000-0002-4795-2004","https://orcid.org/0000-0002-5997-4585"]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Qifeng Zhang","raw_affiliation_strings":["4Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006778176","display_name":"Elizabeth A. Smethurst","orcid":"https://orcid.org/0000-0001-8760-5886","observed_orcids":["https://orcid.org/0000-0001-8760-5886"]},"institutions":[{"id":"https://openalex.org/I2801316944","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I2801316944"]},{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Elizabeth A. Smethurst","raw_affiliation_strings":["2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","5Cancer Research UK, Angel Building, Clerkenwell, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]},{"raw_affiliation_string":"5Cancer Research UK, Angel Building, Clerkenwell, London, United Kingdom","institution_ids":["https://openalex.org/I2801316944"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000153144","display_name":"Zachary T. Schug","orcid":"https://orcid.org/0000-0003-4197-8227","observed_orcids":["https://orcid.org/0000-0003-4197-8227"]},"institutions":[{"id":"https://openalex.org/I102322052","display_name":"The Wistar Institute","ror":"https://ror.org/04wncat98","country_code":"US","type":"facility","lineage":["https://openalex.org/I102322052"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary T. Schug","raw_affiliation_strings":["6The Wistar Institute, Philadelphia, Pennsylvania"],"raw_orcid":"https://orcid.org/0000-0003-4197-8227","affiliations":[{"raw_affiliation_string":"6The Wistar Institute, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I102322052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090750181","display_name":"Barrie Peck","orcid":"https://orcid.org/0000-0002-6687-8495","observed_orcids":["https://orcid.org/0000-0002-6687-8495"]},"institutions":[{"id":"https://openalex.org/I142947616","display_name":"Institute of Cancer Research","ror":"https://ror.org/043jzw605","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I142947616"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Barrie Peck","raw_affiliation_strings":["7The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7The Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom","institution_ids":["https://openalex.org/I142947616"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090126935","display_name":"Eric Ofori Aboagye","orcid":"https://orcid.org/0000-0003-2276-6771","observed_orcids":["https://orcid.org/0000-0003-2276-6771"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Eric O. Aboagye","raw_affiliation_strings":["8Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"8Department of Surgery and Cancer, Imperial College London, Hammersmith Hospital, London, United Kingdom","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057710096","display_name":"Susan E. Critchlow","orcid":"https://orcid.org/0000-0002-4647-8988","observed_orcids":["https://orcid.org/0000-0002-4647-8988"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Susan E. Critchlow","raw_affiliation_strings":["9Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"9Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I105036370"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077374712","display_name":"Almut Schulze","orcid":"https://orcid.org/0000-0002-8199-6422","observed_orcids":["https://orcid.org/0000-0002-8199-6422"]},"institutions":[{"id":"https://openalex.org/I4210100919","display_name":"Comprehensive Cancer Center Mainfranken","ror":"https://ror.org/013tmk464","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I25974101","https://openalex.org/I4210100919","https://openalex.org/I4210126310"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Almut Schulze","raw_affiliation_strings":["10Theodor-Boveri-Institute, Bicenter, Am Hubland, W\u00fcrzburg, Germany; and Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany"],"raw_orcid":"https://orcid.org/0000-0002-8199-6422","affiliations":[{"raw_affiliation_string":"10Theodor-Boveri-Institute, Bicenter, Am Hubland, W\u00fcrzburg, Germany; and Comprehensive Cancer Center Mainfranken, W\u00fcrzburg, Germany","institution_ids":["https://openalex.org/I4210100919"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091741754","display_name":"Eyal Gottlieb","orcid":"https://orcid.org/0000-0002-9770-0956","observed_orcids":["https://orcid.org/0000-0002-9770-0956"]},"institutions":[{"id":"https://openalex.org/I174306211","display_name":"Technion \u2013 Israel Institute of Technology","ror":"https://ror.org/03qryx823","country_code":"IL","type":"education","lineage":["https://openalex.org/I174306211"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Eyal Gottlieb","raw_affiliation_strings":["11Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel"],"raw_orcid":"https://orcid.org/0000-0002-9770-0956","affiliations":[{"raw_affiliation_string":"11Rappaport Faculty of Medicine and Research Institute, Technion-Israel Institute of Technology, Haifa, Israel","institution_ids":["https://openalex.org/I174306211"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027660695","display_name":"Michael J.O. Wakelam","orcid":"https://orcid.org/0000-0003-4059-9276","observed_orcids":["https://orcid.org/0000-0003-4059-9276"]},"institutions":[{"id":"https://openalex.org/I1302113299","display_name":"Babraham Institute","ror":"https://ror.org/01d5qpn59","country_code":"GB","type":"facility","lineage":["https://openalex.org/I1302113299","https://openalex.org/I2799693246","https://openalex.org/I4210087105"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Michael J.O. Wakelam","raw_affiliation_strings":["4Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Babraham Institute, Babraham Research Campus, Cambridge, United Kingdom","institution_ids":["https://openalex.org/I1302113299"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079633934","display_name":"Adrian Llewellyn Harris","orcid":"https://orcid.org/0000-0003-1376-8409","observed_orcids":["https://orcid.org/0000-0003-1376-8409","https://orcid.org/0000-0002-5222-4765"]},"institutions":[{"id":"https://openalex.org/I2802742124","display_name":"John Radcliffe Hospital","ror":"https://ror.org/0080acb59","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2802742124","https://openalex.org/I4210127145","https://openalex.org/I4210147381"]},{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]},{"id":"https://openalex.org/I4210110594","display_name":"MRC Weatherall Institute of Molecular Medicine","ror":"https://ror.org/01q496a73","country_code":"GB","type":"facility","lineage":["https://openalex.org/I40120149","https://openalex.org/I4210087105","https://openalex.org/I4210110594","https://openalex.org/I90344618"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Adrian L. Harris","raw_affiliation_strings":["2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Molecular Oncology Laboratories, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom","institution_ids":["https://openalex.org/I2802742124","https://openalex.org/I40120149","https://openalex.org/I4210110594"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5011978635"],"corresponding_institution_ids":["https://openalex.org/I40120149"],"apc_list":null,"apc_paid":null,"fwci":0.9795,"has_fulltext":false,"cited_by_count":27,"citation_normalized_percentile":{"value":0.69397289,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"18","issue":"2","first_page":"376","last_page":"388"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11844","display_name":"Lipid metabolism and biosynthesis","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tumor-lipid-metabolism","display_name":"tumor lipid metabolism","score":0.8679999709129333},{"id":"https://openalex.org/keywords/tumor-spheroids","display_name":"tumor spheroids","score":0.8460000157356262},{"id":"https://openalex.org/keywords/kinase-inhibitors","display_name":"kinase inhibitors","score":0.7900000214576721},{"id":"https://openalex.org/keywords/fatty-acid-synthase","display_name":"fatty acid synthase","score":0.9350000023841858},{"id":"https://openalex.org/keywords/acetyl-coa-carboxylase","display_name":"acetyl-CoA carboxylase","score":0.996999979019165},{"id":"https://openalex.org/keywords/pyruvate-dehydrogenase-kinase","display_name":"pyruvate dehydrogenase kinase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.8999999761581421},{"id":"https://openalex.org/keywords/lipidomics","display_name":"lipidomics","score":0.7179999947547913},{"id":"https://openalex.org/keywords/phosphatidylcholine","display_name":"phosphatidylcholine","score":0.859000027179718},{"id":"https://openalex.org/keywords/kennedy-pathway","display_name":"Kennedy pathway","score":0.9869999885559082},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.8090000152587891},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/mda-mb-468-cells","display_name":"MDA-MB-468","score":0.8740000128746033},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.9079999923706055},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.42100000381469727},{"id":"https://openalex.org/keywords/de-novo-lipogenesis","display_name":"de novo lipogenesis","score":0.7369999885559082}],"concepts":[{"id":"https://openalex.org/C4733338","wikidata":"https://www.wikidata.org/wiki/Q2792936","display_name":"Lipid metabolism","level":2,"score":0.8109058737754822},{"id":"https://openalex.org/C48289651","wikidata":"https://www.wikidata.org/wiki/Q106916817","display_name":"Fatty acid synthase","level":3,"score":0.6613549590110779},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6178409457206726},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.5306994318962097},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.513494074344635},{"id":"https://openalex.org/C25095133","wikidata":"https://www.wikidata.org/wiki/Q573950","display_name":"Lipid droplet","level":2,"score":0.49958086013793945},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.4744751751422882},{"id":"https://openalex.org/C2776941171","wikidata":"https://www.wikidata.org/wiki/Q900209","display_name":"Fatty acid synthesis","level":3,"score":0.44158458709716797},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.42790699005126953},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4109220504760742},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.2963654398918152},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2799345850944519}],"mesh":[{"descriptor_ui":"D000103","descriptor_name":"Acetyl-CoA Carboxylase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002470","descriptor_name":"Cell Survival","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010743","descriptor_name":"Phospholipids","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011471","descriptor_name":"Prostatic Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D018874","descriptor_name":"Spheroids, Cellular","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D018874","descriptor_name":"Spheroids, Cellular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D018874","descriptor_name":"Spheroids, Cellular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018929","descriptor_name":"Cell Culture Techniques","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D049109","descriptor_name":"Cell Proliferation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D050356","descriptor_name":"Lipid Metabolism","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D051048","descriptor_name":"Diacylglycerol O-Acyltransferase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D054890","descriptor_name":"Fatty Acid Synthase, Type I","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1158/1535-7163.mct-17-0857","doi":"https://doi.org/10.1158/1535-7163.mct-17-0857","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-17-0857","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:30478149","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30478149","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Comparative Study"},{"id":"pmh:oai:europepmc.org:5577490","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6611711","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6611711","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6611711","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},{"id":"pmh:oai:qmro.qmul.ac.uk:123456789/62118","doi":null,"is_oa":false,"landing_page_url":"https://qmro.qmul.ac.uk/xmlui/handle/123456789/62118","pdf_url":null,"source":{"id":"https://openalex.org/S4306400530","display_name":"Queen Mary Research Online (Queen Mary University of London)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I166337079","host_organization_name":"Queen Mary University of London","host_organization_lineage":["https://openalex.org/I166337079"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:5577490","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6611711","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Text"},"sustainable_development_goals":[{"score":0.9391000270843506,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"score":0.6700000166893005,"display_name":"Affordable and clean energy","id":"https://metadata.un.org/sdg/7"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G220529981","display_name":"The development of a powerful new lipidomics tool kit underpinning our objectives","funder_award_id":"BBS/E/B/000C0415","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G5276291310","display_name":null,"funder_award_id":"C602/A18974","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G5753548785","display_name":null,"funder_award_id":"BBS/E/B/000C0419","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G6565833886","display_name":null,"funder_award_id":"BBS/E/B/000C0415","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G6705591880","display_name":"A systems approach to understanding lipid, Ca2+ and MAPK signalling networks","funder_award_id":"BBS/E/B/000C0419","funder_id":"https://openalex.org/F4320334629","funder_display_name":"Biotechnology and Biological Sciences Research Council"},{"id":"https://openalex.org/G8651018663","display_name":null,"funder_award_id":"18974","funder_id":"https://openalex.org/F4320319985","funder_display_name":"Cancer Research UK"},{"id":"https://openalex.org/G9000906427","display_name":"Consolidated Basic Cancer Research Program","funder_award_id":"P30CA010815","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320306260","display_name":"Breast Cancer Research Foundation","ror":"https://ror.org/0348ff195"},{"id":"https://openalex.org/F4320319985","display_name":"Cancer Research UK","ror":"https://ror.org/054225q67"},{"id":"https://openalex.org/F4320334629","display_name":"Biotechnology and Biological Sciences Research Council","ror":"https://ror.org/00cwqg982"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W1486422396","https://openalex.org/W1756026368","https://openalex.org/W1884217239","https://openalex.org/W1975701262","https://openalex.org/W1977222014","https://openalex.org/W1984630839","https://openalex.org/W1985311405","https://openalex.org/W1996575904","https://openalex.org/W2003564623","https://openalex.org/W2014253236","https://openalex.org/W2017399995","https://openalex.org/W2022853846","https://openalex.org/W2027705428","https://openalex.org/W2044515618","https://openalex.org/W2057001750","https://openalex.org/W2058168165","https://openalex.org/W2064318855","https://openalex.org/W2066207556","https://openalex.org/W2070732456","https://openalex.org/W2077328356","https://openalex.org/W2083166156","https://openalex.org/W2091532850","https://openalex.org/W2094093571","https://openalex.org/W2095707070","https://openalex.org/W2101572834","https://openalex.org/W2102416115","https://openalex.org/W2112676571","https://openalex.org/W2116516144","https://openalex.org/W2125872855","https://openalex.org/W2139126860","https://openalex.org/W2141125222","https://openalex.org/W2148378558","https://openalex.org/W2150494760","https://openalex.org/W2152675473","https://openalex.org/W2169611005","https://openalex.org/W2220436777","https://openalex.org/W2314067388","https://openalex.org/W2323791142","https://openalex.org/W2403922329","https://openalex.org/W2472687470","https://openalex.org/W2594862518","https://openalex.org/W2605772872","https://openalex.org/W2621936089","https://openalex.org/W2769383666","https://openalex.org/W2771932126","https://openalex.org/W2773870182","https://openalex.org/W2789281724","https://openalex.org/W4241534679","https://openalex.org/W4243903519"],"related_works":["https://openalex.org/W3047553311","https://openalex.org/W2070847866","https://openalex.org/W3175182180","https://openalex.org/W2172099435","https://openalex.org/W2395187593","https://openalex.org/W2998382082","https://openalex.org/W4281484186","https://openalex.org/W2982343273","https://openalex.org/W2060465647","https://openalex.org/W4407350399"],"abstract_inverted_index":{"Abstract":[0],"Tumor":[1],"cells":[2],"exhibit":[3],"altered":[4,139],"lipid":[5,18,27,41,87,95,130,140,178,185,255],"metabolism":[6,133,230],"compared":[7,149],"with":[8,50,80,150],"normal":[9],"cells.":[10],"Cell":[11],"signaling":[12,73],"kinases":[13,25],"are":[14],"important":[15,229],"for":[16],"regulating":[17],"synthesis":[19,256],"and":[20,45,66,78,101,111,116,123,137,155,195],"energy":[21],"storage.":[22],"How":[23],"upstream":[24],"regulate":[26],"content,":[28],"versus":[29,161,257],"direct":[30],"targeting":[31,222],"of":[32,193,242],"lipid-metabolizing":[33],"enzymes,":[34],"is":[35],"currently":[36],"unexplored.":[37],"We":[38,83],"evaluated":[39],"intracellular":[40],"concentrations":[42],"in":[43,93,97,120,159],"prostate":[44],"breast":[46],"tumor":[47,215,243,250],"spheroids,":[48],"treated":[49],"drugs":[51,221],"directly":[52],"inhibiting":[53,147],"metabolic":[54],"enzymes":[55,75],"fatty":[56],"acid":[57],"synthase":[58],"(FASN),":[59],"acetyl-CoA":[60],"carboxylase":[61],"(ACC),":[62],"diacylglyceride":[63],"acyltransferase":[64],"(DGAT),":[65],"pyruvate":[67],"dehydrogenase":[68],"kinase":[69,74,151],"(PDHK),":[70],"or":[71,232],"cell":[72,118],"PI3K,":[76,109],"AKT,":[77,110],"mTOR":[79,112],"lipidomic":[81],"analysis.":[82],"assessed":[84],"whether":[85],"baseline":[86,177],"profiles":[88,96,179],"corresponded":[89],"to":[90,104,245],"inhibitors'":[91,157],"effectiveness":[92,158],"modulating":[94],"three-dimensional":[98],"(3D)":[99],"growth":[100,119,148,183,191],"their":[102,234],"relationship":[103],"therapeutic":[105],"activity.":[106],"Inhibitors":[107],"against":[108,135],"significantly":[113],"inhibited":[114],"MDA-MB-468":[115],"PC3":[117],"two-dimensional":[121],"(2D)":[122],"3D":[124],"spheroid":[125],"growth,":[126,216],"while":[127,144],"moderately":[128,146],"altering":[129],"content.":[131],"Conversely,":[132],"inhibitors":[134,231],"FASN":[136,154,194],"DGAT":[138,196],"content":[141],"most":[142],"effectively,":[143],"only":[145],"inhibitors.":[152,197],"The":[153],"ACC":[156],"MDA-MB-468,":[160],"PC3,":[162],"suggested":[163],"the":[164,171,190,209],"former":[165],"depended":[166],"more":[167],"on":[168,187],"synthesis,":[169],"whereas":[170],"latter":[172],"may":[173,227,259],"salvage":[174],"lipids.":[175],"Although":[176],"did":[180],"not":[181],"predict":[182],"effects,":[184],"changes":[186],"therapy":[188],"matched":[189],"effects":[192],"Several":[198],"phospholipids,":[199],"including":[200],"phosphatidylcholine,":[201],"were":[202],"also":[203],"upregulated":[204],"following":[205],"treatment,":[206],"possibly":[207],"via":[208],"Kennedy":[210],"pathway.":[211],"As":[212],"this":[213],"promotes":[214],"combination":[217],"studies":[218,237],"should":[219,238],"include":[220],"it.":[223],"Two-dimensional":[224],"drug":[225],"screening":[226],"miss":[228],"underestimate":[233],"potency.":[235],"Clinical":[236],"consider":[239],"serial":[240],"measurements":[241],"lipids":[244],"prove":[246],"target":[247],"modulation.":[248],"Pretherapy":[249],"classification":[251],"by":[252],"de":[253],"novo":[254],"uptake":[258],"help":[260],"demonstrate":[261],"efficacy.":[262]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":6},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-12-11T00:00:00"}